MENU
ACRV
AS OF
Jan 16, 04:59 PM (EDT)
Price
$1.98
Change
+$0.11 (+5.88%)
Capitalization
59.01M
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 157.45% to -121 cents per share on March 26

Acrivon Therapeutics ACRV Stock Earnings Reports
Q4'25
Est.
$-1.21
Q3'25
Beat
by $0.69
Q2'25
Beat
by $0.54
Q1'25
Beat
by $0.50
Q4'24
Beat
by $0.17
The last earnings report on November 13 showed earnings per share of -46 cents, beating the estimate of -115 cents. With 1.38M shares outstanding, the current market capitalization sits at 59.01M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ACRV
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACRV showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ACRV
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com